Presentation COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease Presenter: S. Acharjee July 31, 2015
Presentation TCT 2015 From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA? Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore October 11, 2015
Presentation TCT 2012 Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES? Presenter: Dean Kereiakes October 22, 2012
Presentation BIT 2020 Ischemia, Orbita, Courage trials will bring down Coronary Revascularization Significantly Presenter: Baren Chakraborty February 02, 2020
Presentation Predicting Outcome in the COURAGE Trial: Coronary Anatomy vs. Ischemia Presenter: G.B. John Mancini January 14, 2014
Presentation TCT 2013 On the PROSPECT of Reconciling COURAGE and FAME Presenter: Jagat Narula October 30, 2013
Presentation TCTAP 2013 The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax Presenter: Seung-Jung Park April 24, 2013
Presentation TCT 2012 The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients. Presenter: David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff January 03, 2012
Presentation TCT 2015 For This Patient, I Suggest Medical Management and Risk-Factor Reduction Alone (What Have COURAGE and FAME Taught Us?) Presenter: John D. Puskas, Michael E. Farkouh October 14, 2015
Presentation Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE Presenter: Arun V. Mohan December 26, 2013
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane October 12, 2015
Presentation Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in COURAGE Presenter: John A. Spertus July 17, 2013
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara October 12, 2015
Presentation Controversies and Advances 2021 Treating Stenosis or Ischemia Does Not Improve Clinical Outcomes – Medical Therapy Is King (and Queen) Presenter: William E. Boden December 03, 2021